{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:33:52Z","timestamp":1772890432084,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Molecules"],"abstract":"<jats:p>We investigated the antihypertensive effect of policosanol on spontaneously hypertensive rats (SHR). For this, we analyzed blood pressure, blood lipid, and lipoprotein properties in male SHR after consumption of Cuban policosanol (PCO). The experimental groups were as follows: normotensive Wistar Kyoto (WKY) control, SHR group fed normal diet (ND), SHR group fed 20 mg of PCO, SHR group fed 100 mg of PCO, and SHR group fed 200 mg of PCO per kg of body weight. After eight weeks, the SHR control group showed gradual increases up to 22% in systolic blood pressure (SBP) and 17.6% in the diastolic blood pressure (DBP) compared with values at week 0. However, policosanol consumption had a dose-dependent reduction effect on SBP and also reduced DBP up to 16% in a dose-dependent manner. Heart rate (HR) bpm increased by six percent in the SHR control, whereas the 20 mg, 100 mg, and 200 mg of policosanol groups showed a reduction of 36%, 28%, and 34% respectively. Although serum total cholesterol (TC) level of SHR was not affected by policosanol consumption (70\u201380 mg\/dL), serum triglyceride (TG) level significantly decreased in the SHR + 200 mg of PCO group. Serum high-density lipoprotein cholesterol (HDL-C) level was also significantly elevated by policosanol consumption. The % HDL-C\/TC ratio was elevated in the policosanol group up to 67\u201370%, whereas the SHR control group showed a ratio of 58%. Serum cholesteryl ester transfer protein (CETP) activity was reduced by policosanol in a dose-dependent manner. Although the serum glutamate oxaloacetate transaminase (GOT)\/ glutamate pyruvate transaminase (GPT) were similar across all groups, policosanol consumption caused reduction of reactive oxygen species (ROS) levels in hepatic tissue. The SHR control group showed a 2.1-fold higher serum C-reactive protein (CRP) level than the WKY group, whereas the CRP level decreased in the SHR + 200 mg of PCO group (up to 45%) than SHR control group. Aldosterone level was reduced in the policosanol group (up to 34%) in a dose-dependent manner compared to the control. In conclusion, eight weeks of policosanol consumption in SHR resulted in remarkable reduction of blood pressure, serum aldosterone, and serum TG levels along with the elevation of HDL-C and improvement of hepatic inflammation.<\/jats:p>","DOI":"10.3390\/molecules23051080","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T03:08:21Z","timestamp":1525403301000},"page":"1080","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Blood Pressure Lowering Effect of Cuban Policosanol is Accompanied by Improvement of Hepatic Inflammation, Lipoprotein Profile, and HDL Quality in Spontaneously Hypertensive Rats"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-4140","authenticated-orcid":false,"given":"Kyung-Hyun","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Korea"},{"name":"Research Institute of Protein Sensor, Yeungnam University, Gyeongsan 712-749, Korea"},{"name":"LipoLab, Daehak-Ro 280, Gyeongsan 712-749, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-7236","authenticated-orcid":false,"given":"Dhananjay","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Korea"},{"name":"Research Institute of Protein Sensor, Yeungnam University, Gyeongsan 712-749, Korea"},{"name":"LipoLab, Daehak-Ro 280, Gyeongsan 712-749, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk-Jeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Yeungnam University, Gyeongsan 712-749, Korea"},{"name":"Research Institute of Protein Sensor, Yeungnam University, Gyeongsan 712-749, Korea"},{"name":"LipoLab, Daehak-Ro 280, Gyeongsan 712-749, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ryong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Smart-Aging Convergence Research Center, College of Medicine, Yeungnam University, Daegu 705-717, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/eurheartj\/ehn061","article-title":"Dyslipidaemia as a predictor of hypertension in middle-aged men","volume":"29","author":"Laaksonen","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/HJH.0000000000000941","article-title":"Association of triglycerides and new lipid markers with the incidence of hypertension in a spanish cohort","volume":"34","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4330\/wjc.v6.i6.353","article-title":"Essential hypertension and oxidative stress: New insights","volume":"6","author":"Valls","year":"2014","journal-title":"World J. Cardiol."},{"key":"ref_4","unstructured":"Boyce, G., Button, E., Soo, S., and Wellington, C. (2017). The pleiotropic vasoprotective functions of high density lipoproteins (HDL). J. Biomed. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gong, J., Qin, X., Yuan, F., Hu, M., Chen, G., Fang, K., Wang, D., Jiang, S., Li, J., and Zhao, Y. (2018). Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Mol. Nutr. Food Res., 62.","DOI":"10.1002\/mnfr.201700280"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/rej.2015.1712","article-title":"Enhancement of high-density lipoprotein cholesterol functions by encapsulation of policosanol exerts anti-senescence and tissue regeneration effects via improvement of anti-glycation, anti-apoptosis, and cholesteryl ester transfer inhibition","volume":"19","author":"Lim","year":"2016","journal-title":"Rejuvenation Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/rej.2015.1745","article-title":"Anti-aging and tissue regeneration ability of policosanol along with lipid-lowering effect in hyperlipidemic zebrafish via enhancement of high-density lipoprotein functionality","volume":"19","author":"Lee","year":"2016","journal-title":"Rejuvenation Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.106.107144","article-title":"Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of amp-kinase","volume":"318","author":"Singh","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3892\/ijmm.2017.2907","article-title":"Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects","volume":"39","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fphys.2018.00412","article-title":"Long-term consumption of cuban policosanol lowers central and brachial blood pressure and improves lipid profile with enhancement of lipoprotein properties in healthy korean participants","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00126839-200203030-00004","article-title":"Effects of policosanol on older patients with hypertension and type ii hypercholesterolaemia","volume":"3","author":"Castano","year":"2002","journal-title":"Drugs R D"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.48.3.309","article-title":"Similarities of genetic (spontaneous) hypertension. Man and rat","volume":"48","author":"Trippodo","year":"1981","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.HYP.22.1.97","article-title":"Circadian blood pressure variation in transgenic hypertensive rats","volume":"22","author":"Lemmer","year":"1993","journal-title":"Hypertension"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"528757","DOI":"10.1155\/2015\/528757","article-title":"Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis","volume":"2015","author":"Leong","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_15","first-page":"349","article-title":"Animal models of hypertension and effect of drugs","volume":"35","author":"Badyal","year":"2003","journal-title":"Indian J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pharep.2013.08.006","article-title":"The effects of celiprolol on serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats","volume":"66","author":"Andrzejczak","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wu, M., Peng, Z., Zu, C., Ma, J., Lu, S., Zhong, J., and Zhang, S. (2016). Losartan attenuates myocardial endothelial-to-mesenchymal transition in spontaneous hypertensive rats via inhibiting TGF-\u03b2\/Smad Signaling. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155730"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/eurheartj\/ehr348","article-title":"Torcetrapib impairs endothelial function in hypertension","volume":"33","author":"Simic","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.7754\/Clin.Lab.2015.150202","article-title":"The Relationship Between Lipoprotein-Associated Phospholipase A(2), Cholesteryl Ester Transfer Protein and Lipid Profile and Risk of Atherosclerosis in Women with Iron Deficiency Anaemia","volume":"61","author":"Yang","year":"2015","journal-title":"Clin. Lab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3858\/emm.2009.41.2.009","article-title":"Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients","volume":"41","author":"Cho","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacl.2017.08.020","article-title":"Cord and maternal sera from small neonates share dysfunctional lipoproteins with proatherogenic properties: Evidence for Barker\u2019s hypothesis","volume":"11","author":"Kim","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0305-0491(82)90252-8","article-title":"Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species","volume":"71","author":"Ha","year":"1982","journal-title":"Comp. Biochem. Physiol. Part B Comp. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2010.08.003","article-title":"Update on CETP inhibition","volume":"4","author":"Davidson","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/HJH.0b013e3283450223","article-title":"Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community","volume":"29","author":"Zachariah","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jphp.12287","article-title":"Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults","volume":"66","author":"Suico","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1009744","article-title":"Safety of anacetrapib in patients with or at high risk for coronary heart disease","volume":"363","author":"Cannon","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/hr.2015.131","article-title":"Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population","volume":"39","author":"Mayer","year":"2016","journal-title":"Hypertens. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5539\/gjhs.v7n5p159","article-title":"Body weight reduction results in favorable changes in blood pressure, serum lipids, and blood sugar in middle-aged japanese persons: A 5-year interval observational study of 26,824 cases","volume":"7","author":"Mandai","year":"2015","journal-title":"Glob. J. Health Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1194\/jlr.R024075","article-title":"Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk","volume":"53","author":"Barter","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.jacc.2010.01.032","article-title":"Aldosterone\/renin ratio determines peripheral and central blood pressure values over a broad range","volume":"55","author":"Tomaschitz","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.mcna.2009.02.014","article-title":"The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative Stress","volume":"93","author":"Manrique","year":"2009","journal-title":"Med. Clin. N. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.7326\/0003-4819-68-5-1164_1","article-title":"The renin-angiotensin-aldosterone system in hypertension","volume":"68","author":"Streeten","year":"1968","journal-title":"Ann. Intern. Med."},{"key":"ref_34","unstructured":"Malkoff, J. (2005). Non-invasive blood pressure for mice and rats. Anim. Lab News Kent Sci. Corp., 1\u201312."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MAJ.0b013e318063c6f7","article-title":"Blood volume measurement as a tool in diagnosing syncope","volume":"334","author":"Calcatti","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.niox.2006.04.264","article-title":"Elevated circulating levels of markers of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome","volume":"15","author":"Yamaguchi","year":"2006","journal-title":"Nitric Oxide"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Pravenec, M., Kajiya, T., Z\u00eddek, V., Landa, V., Mlejnek, P., \u0160im\u00e1kov\u00e1, M., \u0160ilhav\u00fd, J., Mal\u00ednsk\u00e1, H., and Oliyarnyk, O. (2011). Effects of Human C-Reactive Protein on Pathogenesis of Features of the Metabolic Syndrome. Hypertension, 57.","DOI":"10.1161\/HYPERTENSIONAHA.110.164350"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","article-title":"A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples","volume":"87","author":"Markwell","year":"1978","journal-title":"Anal. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1811199a0","article-title":"Antioxidant determinations by the use of a stable free radical","volume":"181","author":"Blois","year":"1958","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10715768909073429","article-title":"Continuous monitoring of in vitro oxidation of human low density lipoprotein","volume":"6","author":"Esterbauer","year":"1989","journal-title":"Free Radic. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)42680-X","article-title":"Electrophoretic separation of plasma lipoproteins in agarose gel","volume":"9","author":"Noble","year":"1968","journal-title":"J. Lipid Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10059-009-0037-8","article-title":"Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: The functional role of apoC-III in rHDL","volume":"27","author":"Cho","year":"2009","journal-title":"Mol. Cells"},{"key":"ref_44","first-page":"1126","article-title":"The human serum paraoxonase\/arylesterase polymorphism","volume":"35","author":"Eckerson","year":"1983","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","first-page":"129","article-title":"The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity","volume":"25","author":"Park","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng.2007.50","article-title":"Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint","volume":"40","author":"Yavari","year":"2008","journal-title":"Nat. Genet."}],"updated-by":[{"DOI":"10.3390\/molecules24010194","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000}}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/5\/1080\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:39:22Z","timestamp":1754260762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/5\/1080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["molecules23051080"],"URL":"https:\/\/doi.org\/10.3390\/molecules23051080","relation":{"correction":[{"id-type":"doi","id":"10.3390\/molecules24010194","asserted-by":"object"}]},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]}}}